Quadrant Capital Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$492K Sell
1,962
-27
-1% -$6.72K 0.01% 904
2025
Q4
$547K Hold
1,989
0.02% 869
2025
Q3
$522K Buy
1,989
+18
+0.9% +$4.38K 0.02% 854
2025
Q2
$431K Sell
1,971
-653
-25% -$140K 0.02% 961
2025
Q1
$587K Buy
2,624
+1,998
+319% +$551K 0.02% 630
2024
Q4
$205K Buy
626
+32
+5% +$10.1K 0.01% 666
2024
Q3
$178K Sell
594
-63
-10% -$19.3K 0.01% 764
2024
Q2
$216K Sell
657
-125
-16% -$44.2K 0.02% 608
2024
Q1
$309K Sell
782
-31
-4% -$11.5K 0.02% 456
2023
Q4
$286K Buy
813
+11
+1% +$3.89K 0.02% 465
2023
Q3
$301K Buy
802
+69
+9% +$26.7K 0.03% 396
2023
Q2
$280K Buy
733
+18
+3% +$6.43K 0.03% 402
2023
Q1
$248K Buy
715
+209
+41% +$61.1K 0.03% 442
2022
Q4
$119K Buy
506
+13
+3% +$3.08K 0.01% 690
2022
Q3
$121K Sell
493
-65
-12% -$19.8K 0.02% 604
2022
Q2
$169K Buy
558
+85
+18% +$27.7K 0.02% 469
2022
Q1
$194K Buy
473
+43
+10% +$16.8K 0.02% 457
2021
Q4
$202K Buy
430
+60
+16% +$25.8K 0.02% 440
2021
Q3
$157K Buy
370
+16
+5% +$6.75K 0.02% 468
2021
Q2
$127K Buy
354
+16
+5% +$5.29K 0.02% 524
2021
Q1
$95K Buy
338
+95
+39% +$27.2K 0.02% 594
2020
Q4
$69K Sell
243
-37
-13% -$10.4K 0.01% 640
2020
Q3
$77K Buy
280
+75
+37% +$19.8K 0.02% 519
2020
Q2
$47K Sell
205
-411
-67% -$80.8K 0.01% 746
2020
Q1
$95K Buy
616
+63
+11% +$9.7K 0.02% 605
2019
Q4
$81K Hold
553
0.01% 1091
2019
Q3
$76K Hold
553
0.01% 1036
2019
Q2
$66K Buy
553
+235
+74% +$27.7K 0.01% 1080
2019
Q1
$32K Buy
318
+215
+209% +$22.4K 0.01% 1373
2018
Q4
$9K Hold
103
﹤0.01% 1441
2018
Q3
$11K Hold
103
﹤0.01% 1251
2018
Q2
$9K Buy
103
+1
+1% +$92 ﹤0.01% 1329
2018
Q1
$8K Hold
102
﹤0.01% 1371
2017
Q4
$9K Hold
102
﹤0.01% 1235
2017
Q3
$9K Buy
102
+26
+34% +$2.35K ﹤0.01% 1236
2017
Q2
$2K Hold
76
﹤0.01% 1625
2017
Q1
$5K Buy
76
+53
+230% +$4.43K ﹤0.01% 1347
2016
Q4
$1K Hold
23
﹤0.01% 1838
2016
Q3
$1K Hold
23
﹤0.01% 1823
2016
Q2
$1K Buy
+23
New +$1.67K ﹤0.01% 1801

Other funds holding WST